Guillermo Canudo Barreras
@gcanudo-barreras.bsky.social
import 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘢𝘭_𝘊𝘩𝘦𝘮𝘪𝘴𝘵𝘳𝘺;
import 𝘋𝘳𝘶𝘨_𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵;
import 𝘉𝘪𝘰𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘤𝘴;
import 𝘊𝘰𝘥𝘪𝘯𝘨;
class 𝘎𝘊𝘢𝘯𝘶𝘥𝘰-𝘉𝘢𝘳𝘳𝘦𝘳𝘢𝘴 extends 𝘗𝘩𝘋_𝘐𝘯𝘰𝘳𝘨𝘢𝘯𝘪𝘤_𝘊𝘩𝘦𝘮𝘪𝘴𝘵𝘳𝘺, 𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘦𝘳 {}
import 𝘋𝘳𝘶𝘨_𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵;
import 𝘉𝘪𝘰𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘤𝘴;
import 𝘊𝘰𝘥𝘪𝘯𝘨;
class 𝘎𝘊𝘢𝘯𝘶𝘥𝘰-𝘉𝘢𝘳𝘳𝘦𝘳𝘢𝘴 extends 𝘗𝘩𝘋_𝘐𝘯𝘰𝘳𝘨𝘢𝘯𝘪𝘤_𝘊𝘩𝘦𝘮𝘪𝘴𝘵𝘳𝘺, 𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘦𝘳 {}
Now #OpenAccess in Journal of Medicinal Chemistry!
We present ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage | pubs.acs.org/doi/10.1021/...
Congratulations and thanks to @conchitagimeno.bsky.social, R. P. Herrera and E. Romanos 🐁📊💊
#3Rs #oncology
We present ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage | pubs.acs.org/doi/10.1021/...
Congratulations and thanks to @conchitagimeno.bsky.social, R. P. Herrera and E. Romanos 🐁📊💊
#3Rs #oncology
ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage
Preclinical tumor studies are often limited by high variability and small-sample sizes, reducing statistical power, and masking treatment effects. We present an exponential framework that estimates tu...
pubs.acs.org
January 3, 2026 at 5:45 PM
Now #OpenAccess in Journal of Medicinal Chemistry!
We present ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage | pubs.acs.org/doi/10.1021/...
Congratulations and thanks to @conchitagimeno.bsky.social, R. P. Herrera and E. Romanos 🐁📊💊
#3Rs #oncology
We present ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage | pubs.acs.org/doi/10.1021/...
Congratulations and thanks to @conchitagimeno.bsky.social, R. P. Herrera and E. Romanos 🐁📊💊
#3Rs #oncology
🧬 We just launched 𝐕𝐢𝐕𝐨! An open-source platform for 𝘪𝘯 𝘷𝘪𝘷𝘰 efficacy assays.
Built with automated tumor kinetic analysis to boost preclinical oncology while minimizing animal usage.
📚 Methodology: doi.org/10.1101/2025...
🐁 Try: gcanudo-barreras.github.io/ViVo-Platfor...
#OpenScience #Oncology
Built with automated tumor kinetic analysis to boost preclinical oncology while minimizing animal usage.
📚 Methodology: doi.org/10.1101/2025...
🐁 Try: gcanudo-barreras.github.io/ViVo-Platfor...
#OpenScience #Oncology
ViVo: A temporal modeling framework that boosts statistical power and minimizes animal usage
Preclinical tumor studies are often limited by high variability and small sample sizes, reducing statistical power and masking treatment effects. We present an exponential framework that estimates tum...
doi.org
October 16, 2025 at 10:09 AM
🧬 We just launched 𝐕𝐢𝐕𝐨! An open-source platform for 𝘪𝘯 𝘷𝘪𝘷𝘰 efficacy assays.
Built with automated tumor kinetic analysis to boost preclinical oncology while minimizing animal usage.
📚 Methodology: doi.org/10.1101/2025...
🐁 Try: gcanudo-barreras.github.io/ViVo-Platfor...
#OpenScience #Oncology
Built with automated tumor kinetic analysis to boost preclinical oncology while minimizing animal usage.
📚 Methodology: doi.org/10.1101/2025...
🐁 Try: gcanudo-barreras.github.io/ViVo-Platfor...
#OpenScience #Oncology
Excited to share some of our latest work with @conchitagimeno.bsky.social on light-tracing organometallic drugs at the XL Bienal of @rseq-quimica.bsky.social in Bilbao!
July 3, 2025 at 7:38 AM
Excited to share some of our latest work with @conchitagimeno.bsky.social on light-tracing organometallic drugs at the XL Bienal of @rseq-quimica.bsky.social in Bilbao!
Talking a bit about our recent work on quantifying tumor growth through tumor kinetics modeling at the IV Symposium on Molecular Chemistry and Catalysis organized by #ISQCH.
#DrugDevelopment #MedicinalChemistry #CancerResearch #Pharmacokinetics #ChemistryResearch
#DrugDevelopment #MedicinalChemistry #CancerResearch #Pharmacokinetics #ChemistryResearch
June 6, 2025 at 9:27 AM
Talking a bit about our recent work on quantifying tumor growth through tumor kinetics modeling at the IV Symposium on Molecular Chemistry and Catalysis organized by #ISQCH.
#DrugDevelopment #MedicinalChemistry #CancerResearch #Pharmacokinetics #ChemistryResearch
#DrugDevelopment #MedicinalChemistry #CancerResearch #Pharmacokinetics #ChemistryResearch
In today’s episode of “Science, Please Stop”, salmon on benzos are throwing caution (and themselves) to the current.
Truth is stranger than fiction.
𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘈𝘥𝘷𝘪𝘴𝘦𝘳: 𝘉𝘦𝘯𝘻𝘰𝘴 𝘭𝘦𝘢𝘥 𝘵𝘰 𝘳𝘪𝘴𝘬𝘺 𝘣𝘦𝘩𝘢𝘷𝘪𝘰𝘳—𝘪𝘯 𝘴𝘢𝘭𝘮𝘰𝘯
www.science.org/content/arti...
Truth is stranger than fiction.
𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘈𝘥𝘷𝘪𝘴𝘦𝘳: 𝘉𝘦𝘯𝘻𝘰𝘴 𝘭𝘦𝘢𝘥 𝘵𝘰 𝘳𝘪𝘴𝘬𝘺 𝘣𝘦𝘩𝘢𝘷𝘪𝘰𝘳—𝘪𝘯 𝘴𝘢𝘭𝘮𝘰𝘯
www.science.org/content/arti...
ScienceAdviser: Benzos lead to risky behavior—in salmon
Today in Science and science: Evidence against ‘digital dementia’, what we’re enjoying this week, and more
www.science.org
April 15, 2025 at 8:13 PM
In today’s episode of “Science, Please Stop”, salmon on benzos are throwing caution (and themselves) to the current.
Truth is stranger than fiction.
𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘈𝘥𝘷𝘪𝘴𝘦𝘳: 𝘉𝘦𝘯𝘻𝘰𝘴 𝘭𝘦𝘢𝘥 𝘵𝘰 𝘳𝘪𝘴𝘬𝘺 𝘣𝘦𝘩𝘢𝘷𝘪𝘰𝘳—𝘪𝘯 𝘴𝘢𝘭𝘮𝘰𝘯
www.science.org/content/arti...
Truth is stranger than fiction.
𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘈𝘥𝘷𝘪𝘴𝘦𝘳: 𝘉𝘦𝘯𝘻𝘰𝘴 𝘭𝘦𝘢𝘥 𝘵𝘰 𝘳𝘪𝘴𝘬𝘺 𝘣𝘦𝘩𝘢𝘷𝘪𝘰𝘳—𝘪𝘯 𝘴𝘢𝘭𝘮𝘰𝘯
www.science.org/content/arti...
What often scares us most about AI are the very behaviors we exhibit ourselves.
Take the "reward hacking" phenomenon, where models try to bypass system rules to optimize outcomes. It feels like cheating—but maybe it's just one of the earliest signs of intelligence, artificial or natural.
Take the "reward hacking" phenomenon, where models try to bypass system rules to optimize outcomes. It feels like cheating—but maybe it's just one of the earliest signs of intelligence, artificial or natural.
April 12, 2025 at 8:56 PM
What often scares us most about AI are the very behaviors we exhibit ourselves.
Take the "reward hacking" phenomenon, where models try to bypass system rules to optimize outcomes. It feels like cheating—but maybe it's just one of the earliest signs of intelligence, artificial or natural.
Take the "reward hacking" phenomenon, where models try to bypass system rules to optimize outcomes. It feels like cheating—but maybe it's just one of the earliest signs of intelligence, artificial or natural.
Hello, World!
March 26, 2025 at 2:52 PM
Hello, World!